000 01247 a2200337 4500
005 20250513105709.0
264 0 _c19970108
008 199701s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1996.tb52688.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHellerqvist, C G
245 0 0 _aModulation of interleukin-12 mRNA expression in leukocytes of cancer patients treated with CM101.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cOct 1996
300 _a346-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aInterleukin-12
_xgenetics
650 0 4 _aLeukocyte Count
_xdrug effects
650 0 4 _aPolysaccharides, Bacterial
_xtherapeutic use
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aReceptors, Interleukin
_xgenetics
650 0 4 _aReceptors, Interleukin-12
650 0 4 _aTime Factors
700 1 _aLloyd, R S
700 1 _aWang, E
700 1 _aBardhan, S
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 795
_gp. 346-8
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1996.tb52688.x
_zAvailable from publisher's website
999 _c8950854
_d8950854